Related Experiment Video
Updated: May 15, 2026
High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
miRNA-30a-5p-mediated silencing of Beta2/NeuroD expression is an important initial event of glucotoxicity-induced
1Department of Endocrinology and Metabolism, Seoul St Mary's Hospital, The Catholic University of Korea, # 505, Banpo-Dong, Seocho-Gu, Seoul 137-040, Korea.
Aims/Hypothesis:
The loss of beta cell function is a critical factor in the development of type 2 diabetes. Glucotoxicity plays a major role in the progressive deterioration of beta cell function and development of type 2 diabetes mellitus. Here we demonstrate that microRNA (miR)-30a-5p is a key player in early-stage glucotoxicity-induced beta cell dysfunction.
Methods:
We performed northern blots, RT-PCR and western blots in glucotoxicity-exposed primary rat islets and INS-1 cells. We also measured glucose-stimulated insulin secretion and insulin content. In vivo approaches were used to evaluate the role of miR-30a-5p in beta cell dysfunction.
Results:
miR-30a-5p expression was increased in beta cells after exposure to glucotoxic conditions, and exogenous miR-30a-5p overexpression also induced beta cell dysfunction in vitro. miR-30a-5p directly suppressed expression of Beta2/NeuroD (also known as Neurod1) by binding to a specific binding site in its 3'-untranslated region. After restoration of Beta2/NeuroD expression by knockdown miR-30a-5p or transfection of the Beta2/NeuroD gene, beta cell dysfunction, including decreased insulin content, gene expression and glucose-stimulated insulin secretion, recovered. Glucose tolerance and beta cell dysfunction improved on direct injection of Ad-si30a-5p into the pancreas of diabetic mice.
Conclusions/Interpretation:
Our data demonstrate that miR-30a-5p-mediated direct suppression of Beta2/NeuroD gene expression is an important initiation step of glucotoxicity-induced beta cell dysfunction.
Insights
MicroRNA-30a-5p drives early type 2 diabetes by impairing beta cell function. Restoring Beta2/NeuroD expression reverses this glucotoxicity-induced dysfunction in cells and diabetic mice.
Area of Science:
- Endocrinology
- Molecular Biology
- Diabetes Research
Background:
- Beta cell dysfunction is central to type 2 diabetes development.
- Glucotoxicity significantly contributes to progressive beta cell failure.
- MicroRNAs are increasingly recognized as regulators of cellular function.
Purpose of the Study:
- To investigate the role of microRNA-30a-5p in early glucotoxicity-induced beta cell dysfunction.
- To elucidate the molecular mechanism by which miR-30a-5p affects beta cells.
Main Methods:
- Analysis of miR-30a-5p expression in glucotoxicity-exposed rat islets and INS-1 cells.
- Assessment of glucose-stimulated insulin secretion and insulin content.
- In vivo studies in diabetic mouse models.
Main Results:
- miR-30a-5p expression increased under glucotoxic conditions, causing beta cell dysfunction.
- miR-30a-5p directly targets and suppresses Beta2/NeuroD (Neurod1) expression.
- Restoring Beta2/NeuroD normalized beta cell function and improved glucose tolerance in vivo.
Conclusions:
- miR-30a-5p is a critical mediator of glucotoxicity-induced beta cell dysfunction.
- Direct suppression of Beta2/NeuroD by miR-30a-5p is an early pathogenic event in type 2 diabetes.
- Targeting miR-30a-5p may offer a therapeutic strategy for type 2 diabetes.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs